PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

BENJAMIN KLEIN

BENJAMIN KLEIN appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Aug 31, 2026

Source-backed chronology

Career Timeline

Dates not reported

Legislative Director, Senator Byron Dorgan (2007-2010); Legislative Assistant, Senator Byron Dorgan (2005-2007)

Federal government

Inspect source ↗

Documented career transitions

Revolving Door

Congress → Lobbying

Federal governmentLegislative Director, Senator Byron Dorgan (2007-2010); Legislative Assistant, Senator Byron Dorgan (2005-2007)Palantir TechnologiesRegistered lobbyist

Federal LDA filings

Lobbying Activity

PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2025

Registrant: INVARIANT LLC · Defense

Advocate for funding to support information technology acquisition at the Department of Defense in the FY 26 National Defense Authorization Act. Discuss the importance of funding for the procurement of software for the Department of Defense.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2020

Registrant: INVARIANT LLC · Health Issues

Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2021

Registrant: INVARIANT LLC · Health Issues

Discuss the federal governments use of Palantirs commercial software including efforts for the COVID-19 response; highlight commercial benefits of software solutions; highlight projects within HHS, NIH, and FDA; support federal funding for maintaining systems put in place for the COVID-19 response.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2021

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; encourage support for maintaining systems put in place for COVID-19 to address future public health emergencies.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2021

Registrant: INVARIANT LLC · Disaster Planning/Emergencies

Highlight Palantirs capabilities to support emergency response efforts, including for the COVID-19 pandemic.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2021

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to the USCGs COVID pandemic response and broader readiness efforts.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2021

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; and support funding for the Food and Drug Administrations 21Forward initiative.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2023

Registrant: INVARIANT LLC · Law Enforcement/Crime/Criminal Justice

Support funding for commercial software to help HIDTAS respond to fentanyl and opioid crisis.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S. 3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2025

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2024

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2021

Registrant: INVARIANT LLC · Energy/Nuclear

Educate policymakers on Palantirs capabilities to support federal legacy nuclear site clean-up.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to the USCG and ICE-HSI.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2020

Registrant: INVARIANT LLC · Health Issues

Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2021

Registrant: INVARIANT LLC · Health Issues

Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Transportation

Encourage use of commercial software to maximize infrastructure investments; support funding for the FAA's efforts related to the 5G rollout.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to USCG and ICE-HIS; monitor S. 4802/H.R. 6865, Coast Guard Authorization Act of 2022.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Transportation

Encourage use of commercial software to maximize infrastructure investments; support funding for the FAA's efforts related to the 5G rollout.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to USCG and ICE-HSI; monitor S.4802 / H.R.6865, Coast Guard Authorization Act of 2022.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act. Monitor Pandemic All Hazards Preparedness Act and related legislation, highlighting ongoing work with ASPR.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2023

Registrant: INVARIANT LLC · Law Enforcement/Crime/Criminal Justice

Support funding for commercial software to help HIDTAS respond to fentanyl and opioid crisis.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2024

Registrant: INVARIANT LLC · Defense

Advocate for funding to support information technology acquisition at the Department of Defense. Discuss the importance of funding for the procurement of software.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2024

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All- Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Support funding for ASPR Supply Chain Control Tower.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2024

Registrant: INVARIANT LLC · Defense

Advocate for funding to support information technology acquisition at the Department of Defense. Discuss the importance of funding for the procurement of software.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2024

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2024

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2021

Registrant: INVARIANT LLC · Homeland Security

Educate and support commercial software options for government use; monitor draft Coast Guard Reauthorization.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2021

Registrant: INVARIANT LLC · Disaster Planning/Emergencies

Highlight Palantirs capabilities to support emergency response efforts, including for the COVID-19 pandemic.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2021

Registrant: INVARIANT LLC · Homeland Security

Educate and support commercial software options for government use; monitor Coast Guard Reauthorization.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administration's 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to the USCG, FAA, and ICE-HSI.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administrations 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2021

Registrant: INVARIANT LLC · Energy/Nuclear

Educate policymakers on Palantirs capabilities to support federal legacy nuclear site clean-up; discuss use of data to inform clean energy and climate policies.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, CDC Data Modernization Initiative, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2025

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗